Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1590/S0034-70942011000200014
Brazilian Journal of Anesthesiology
Review Article

Citocinas e dor

Cytokines and pain

Caio Marcio Barros de Oliveira; Rioko Kimiko Sakata; Adriana Machado Issy; Luis Roberto Gerola; Reynaldo Salomão

Downloads: 1
Views: 1603

Resumo

JUSTIFICATIVA E OBJETIVOS: As citocinas são substâncias necessárias para a resposta inflamatória, favorecendo a cicatrização apropriada da ferida. No entanto, a produção exagerada de citocinas pró-inflamatórias a partir da lesão pode manifestar-se sistemicamente com instabilidade hemodinâmica ou distúrbios metabólicos. O objetivo desta revisão foi descrever os efeitos das citocinas na dor. CONTEÚDO: Este artigo faz uma revisão dos efeitos das citocinas na dor. Em doenças que cursam com processo inflamatório agudo ou crônico, as citocinas podem ser reconhecidas por neurônios e utilizadas para desencadear diversas reações celulares que influenciam na atividade, proliferação e sobrevida da célula imunológica, bem como na produção e atividade de outras citocinas. As citocinas podem ser pró-inflamatórias e anti-inflamatórias. As pró-inflamatórias estão relacionadas com a fisiopatologia das síndromes dolorosas. Foram descritas as células que secretam as citocinas, as citocinas pró-inflamatórias (IL-1, IL-2, IL-6, IL-7 e FNT) e anti-inflamatórias (IL-4, IL-10, IL-13 e FTCβ), as funções de cada citocina e como ocorre a ação dessas substâncias no processamento da dor. CONCLUSÕES: As citocinas desempenham importante papel na dor, agindo através de diferentes mecanismos em vários locais das vias de transmissão da dor.

Palavras-chave

DOR, Citocinas

Abstract

BACKGROUND AND OBJECTIVES: Cytokines are necessary for the inflammatory response, favoring proper wound healing. However, exaggerated proinflammatory cytokine production can manifest systemically as hemodynamic instability or metabolic derangements. The objective of this review was to describe the effects of cytokines in pain. CONTENTS: This article reviews the effects of cytokines in pain. In diseases with acute or chronic inflammation, cytokines can be recognized by neurons and used to trigger several cell reactions that influence the activity, proliferation, and survival of immune cells, as well as the production and activity of other cytokines. Cytokines can be proinflammatory and anti-inflammatory. Proinflammatory cytokines are related with the pathophysiology of pain syndromes. Cells that secrete proinflammatory (IL-1, IL-2, IL-6, IL-7, and TNF) and anti-inflammatory (IL-4, IL-10, IL-13, and TGFβ) cytokines, the functions of each cytokine, and the action of those compounds on pain processing, have been described. CONCLUSIONS: Cytokines have an important role in pain through different mechanisms in several sites of pain transmission pathways.

Keywords

Cytokines, Interleukins, Nociceptors, Pain

References

Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery. 2000;127:117-126.

Sommer C, White F. Cytokines, Chemokines, and Pain. Pharmacology of Pain. 2010:279-302.

Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45:27-37.

Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev. 1997;10:742-780.

Raeburn CD, Sheppard F, Barsness KA. Cytokines for surgeons. Am J Surg. 2002;183:268-273.

Wolf G, Livshits D, Beilin B. Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice. Brain Behav Immun. 2008;22:1072-1077.

Song P, Zhao ZQ, Liu XY. Expression of IL-2 receptor in dorsal root ganglion neurons and peripheral antinociception. Neuroreport. 2000;11:1433-1436.

Guo H, Zhao ZQ. Inhibition of nociceptive withdrawal reflex by microinjection of interleukin 2 into rat locus coeruleus. Neuropeptides. 2000;34:216-220.

Ali G, Boldrini L, Lucchi M. Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. Br J Cancer. 2009;101:1869-1875.

Chavez AR, Buchser W, Basse PH. Pharmacologic administration of interleukin-2. Ann N Y Acad Sci. 2009;1182:14-27.

Ohira M, Ishiyama K, Tanaka Y. Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. J Clin Invest. 2009;119:3226-3235.

Sellier P, Lafuente-Lafuente C, Bergmann JF. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. ;362:270-271.

Kurtz DM, Tschetter LK, Allred JB. Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. Leuk Lymphoma. 2007;48:1290-1298.

O'Byrne PM. Cytokines or their antagonists for the treatment of asthma. Chest. 2006;130:244-250.

Ren X, Li J, Zhou X. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model. Dermatology. 2009;219:232-238.

Yorimitsu M, Nishida K, Shimizu A. Intra-articular injection of interleukin-4 decreases nitric oxide production by chondrocytes and ameliorates subsequent destruction of cartilage in instability-induced osteoarthritis in rat knee joints. Osteoarthritis Cartilage. 2008;16:764-771.

Gebhard F, Pfetsch H, Steinbach G. Is interleukin 6 an early marker of injury severity following major trauma in humans?. Arch Surg. 2000;135:291-295.

Hong JY, Lim KT. Effect of preemptive epidural analgesia on cytokine response and postoperative pain in laparoscopic radical hysterectomy for cervical cancer. Reg Anesth Pain Med. 2008;33:44-51.

Kato M, Suzuki H, Murakami M. Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgery. J Clin Anesth. 1997;9:293-298.

Asadullah K, Sabat R, Friedrich M. Interleukin-10: an important immunoregulatory cytokine with major impact on psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:185-192.

Docke WD, Asadullah K, Belbe G. Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis. J Leukoc Biol. 2009;85:582-593.

Lee M, Park H, Youn J. Interleukin-10 plasmid construction and delivery for the prevention of type 1 diabetes. Ann N Y Acad Sci. 2006;1079:313-319.

Min CK, Kim BG, Park G. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;39:637-645.

Pott GB, Sailer CA, Porat R. Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects. Eur Cytokine Netw. 2007;18:49-58.

Shavit Y, Fridel K, Beilin B. Postoperative pain management and proinflammatory cytokines: animal and human studies. J Neuroimmune Pharmacol. 2006;1:443-451.

Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82:981-1011.

Obata H, Eisenach JC, Hussain H. Spinal glial activation contributes to postoperative mechanical hypersensitivity in the rat. J Pain. 2006;7:816-822.

Miller RJ, Jung H, Bhangoo SK. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol. 2009:417-449.

Hudmon A, Choi JS, Tyrrell L. Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci. 2008;28:3190-3201.

McMahon S, Bennett D, Bevan S. Inflammatory Mediators and Modulators of Pain. Wall and Melzacks Textbook of Pain. 2006:49-72.

Buvanendran A, Kroin JS, Berger RA. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology. 2006;104:403-410.

Cunha TM, Verri WA Jr, Fukada SY. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor. Eur J Pharmacol. 2007;573:221-229.

Abbadie C, Bhangoo S, De Koninck Y. Chemokines and pain mechanisms. Brain Res Rev. 2009;60:125-134.

Miller RJ, Banisadr G, Bhattacharyya BJ. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol. 2008;198:31-38.

Bhangoo S, Ren D, Miller RJ. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain. 2007;3.

Kawasaki Y, Zhang L, Cheng JK. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008;28:5189-5194.

Niederberger E, Schmidtko A, Coste O. The glutamate transporter GLAST is involved in spinal nociceptive processing. Biochem Biophys Res Commun. 2006;346:393-399.

Puehler W, Zollner C, Brack A. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience. 2004;129:473-479.

Rittner HL, Brack A, Stein C. The other side of the medal: how chemokines promote analgesia. Neurosci Lett. 2008;437:203-208.

5dd6d41a0e8825167613f288 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections